133 related articles for article (PubMed ID: 18484494)
1. Comparison of the ability of various pharmaceutical silicates to amorphize and enhance dissolution of indomethacin upon co-grinding.
Bahl D; Hudak J; Bogner RH
Pharm Dev Technol; 2008; 13(3):255-69. PubMed ID: 18484494
[TBL] [Abstract][Full Text] [Related]
2. Amorphization of Indomethacin by Co-Grinding with Neusilin US2: amorphization kinetics, physical stability and mechanism.
Bahl D; Bogner RH
Pharm Res; 2006 Oct; 23(10):2317-25. PubMed ID: 16927179
[TBL] [Abstract][Full Text] [Related]
3. Amorphization alone does not account for the enhancement of solubility of drug co-ground with silicate: the case of indomethacin.
Bahl D; Bogner RH
AAPS PharmSciTech; 2008; 9(1):146-53. PubMed ID: 18446475
[TBL] [Abstract][Full Text] [Related]
4. One-step continuous extrusion process for the manufacturing of solid dispersions.
Maniruzzaman M; Nair A; Scoutaris N; Bradley MS; Snowden MJ; Douroumis D
Int J Pharm; 2015 Dec; 496(1):42-51. PubMed ID: 26403386
[TBL] [Abstract][Full Text] [Related]
5. Amorphization of itraconazole by inorganic pharmaceutical excipients: comparison of excipients and processing methods.
Grobelny P; Kazakevich I; Zhang D; Bogner R
Pharm Dev Technol; 2015 Jan; 20(1):118-27. PubMed ID: 25312240
[TBL] [Abstract][Full Text] [Related]
6. Preparation and characterization of co-grinded mixtures of aceclofenac and neusilin US2 for dissolution enhancement of aceclofenac.
Vadher AH; Parikh JR; Parikh RH; Solanki AB
AAPS PharmSciTech; 2009; 10(2):606-14. PubMed ID: 19444620
[TBL] [Abstract][Full Text] [Related]
7. New solid self-microemulsifying systems to enhance dissolution rate of poorly water soluble drugs.
Mura P; Valleri M; Cirri M; Mennini N
Pharm Dev Technol; 2012; 17(3):277-84. PubMed ID: 21108583
[TBL] [Abstract][Full Text] [Related]
8. Undesired co-amorphisation of indomethacin and arginine during combined storage at high humidity conditions.
Petry I; Löbmann K; Grohganz H; Rades T; Leopold CS
Int J Pharm; 2018 Jun; 544(1):172-180. PubMed ID: 29669257
[TBL] [Abstract][Full Text] [Related]
9. The Effect of Specific Surface Area of Chitin-Metal Silicate Coprocessed Excipient on the Chemical Decomposition of Cefotaxime Sodium.
Al-Nimry SS; Alkhamis KA; Alzarieni KZ
J Pharm Sci; 2017 Feb; 106(2):570-578. PubMed ID: 27887722
[TBL] [Abstract][Full Text] [Related]
10. Preparation and characterization of spray-dried co-amorphous drug-amino acid salts.
Jensen KT; Blaabjerg LI; Lenz E; Bohr A; Grohganz H; Kleinebudde P; Rades T; Löbmann K
J Pharm Pharmacol; 2016 May; 68(5):615-24. PubMed ID: 26245703
[TBL] [Abstract][Full Text] [Related]
11. Complex effects of drug/silicate ratio, solid-state equivalent pH, and moisture on chemical stability of amorphous quinapril hydrochloride coground with silicates.
Hailu SA; Bogner RH
J Pharm Sci; 2011 Apr; 100(4):1503-15. PubMed ID: 24081473
[TBL] [Abstract][Full Text] [Related]
12. Enhanced kinetic solubility profiles of indomethacin amorphous solid dispersions in poly(2-hydroxyethyl methacrylate) hydrogels.
Sun DD; Ju TC; Lee PI
Eur J Pharm Biopharm; 2012 May; 81(1):149-58. PubMed ID: 22233548
[TBL] [Abstract][Full Text] [Related]
13. Manufacture and performance evaluation of a stable amorphous complex of an acidic drug molecule and Neusilin.
Maclean J; Medina C; Daurio D; Alvarez-Nunez F; Jona J; Munson E; Nagapudi K
J Pharm Sci; 2011 Aug; 100(8):3332-3344. PubMed ID: 21520086
[TBL] [Abstract][Full Text] [Related]
14. Stabilization of amorphous indomethacin by co-grinding in a ternary mixture.
Watanabe T; Ohno I; Wakiyama N; Kusai A; Senna M
Int J Pharm; 2002 Jul; 241(1):103-11. PubMed ID: 12086726
[TBL] [Abstract][Full Text] [Related]
15. Dissolution and powder flow characterization of solid self-emulsified drug delivery system (SEDDS).
Agarwal V; Siddiqui A; Ali H; Nazzal S
Int J Pharm; 2009 Jan; 366(1-2):44-52. PubMed ID: 18832019
[TBL] [Abstract][Full Text] [Related]
16. Influence of the cooling rate and the blend ratio on the physical stability of co-amorphous naproxen/indomethacin.
Beyer A; Grohganz H; Löbmann K; Rades T; Leopold CS
Eur J Pharm Biopharm; 2016 Dec; 109():140-148. PubMed ID: 27746228
[TBL] [Abstract][Full Text] [Related]
17. Practical approach to prepare solid dispersion drug product using spherical silicate.
Nagane K; Kimura S; Ukai K; Ogawa N; Yamamoto H
Int J Pharm; 2014 Nov; 475(1-2):364-71. PubMed ID: 25131150
[TBL] [Abstract][Full Text] [Related]
18. Solid self-microemulsifying drug delivery system of ritonavir.
Deshmukh A; Kulkarni S
Drug Dev Ind Pharm; 2014 Apr; 40(4):477-87. PubMed ID: 23465049
[TBL] [Abstract][Full Text] [Related]
19. Indomethacin-omeprazole as therapeutic hybrids? Salt and co-amorphous systems enhancing physicochemical and pharmacological properties.
Nascimento ALCS; Martins ICB; Spósito L; Morais-Silva G; Duarte JL; Rades T; Chorilli M
Int J Pharm; 2024 Mar; 653():123857. PubMed ID: 38281693
[TBL] [Abstract][Full Text] [Related]
20. Exploring the use of spray congealing to produce solid dispersions with enhanced indomethacin bioavailability: In vitro characterization and in vivo study.
Bertoni S; Albertini B; Ferraro L; Beggiato S; Dalpiaz A; Passerini N
Eur J Pharm Biopharm; 2019 Jun; 139():132-141. PubMed ID: 30910731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
